EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

OPTN/SRTR 2023 Annual Data Report: Heart

Monica M Colvin, Jodi M Smith, Yoon Son Ahn, Kelsi A Lindblad, Dzhuliyana Handarova, Ajay K Israni, Jon J Snyder

American Journal of Transplantation · 2025-02 · 25 (2) · S329-S421

DOI: 10.1016/j.ajt.2025.01.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Transplantation, 2025-02. Verfasst von Monica M Colvin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN; Department of Cardiology, University of Michig…. Hauptthemen laut MEDLINE: Heart Transplantation, Waiting Lists, Tissue and Organ Procurement, Tissue Donors. Die Arbeit wurde bisher 123-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AHRQ HHS, Agency for Healthcare Research and Quality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite unintended consequences and ongoing need for revision, the 2018 adult heart transplant policy revision continues to have a favorable impact as evidenced by increased transplant rates, decreased waitlist mortality, and more rapid transplant in higher acuity patients. In 2023, the total number of heart transplants in the United States increased 101.1% since 2012, reaching a record 4,599, of which 4,092 were performed in adults. Between 2022 and 2023 alone, 424 more adult heart transplants were performed, the largest annual increase this decade. Concurrently, the prevalence of heart donors after circulatory death increased to 14.0% in 2023. Candidates listed at adult statuses 1 and 2 underwent transplant more quickly (2,225.8 and 1,088.1 transplants per 100 patient-years, respectively). In 2023, adult waitlist mortality reached a low: 8.5 deaths per 100 patient-years. Multiorgan transplants (heart-liver and heart-kidney) in adults continue to increase, achieving comparable survival to that of heart transplant alone. Adults with congenital heart disease had the lowest pretransplant mortality of all diagnoses but also the lowest posttransplant survival, 76.1% at 5 years, emphasizing the need for consensus on best practices. In pediatric heart transplant, heart transplants increased 36.3% and new listings increased 34.0%, but the transplant rate decreased 14.9% resulting in increased waiting times. High-urgency listings increased, with 83.6% of heart transplants performed for status 1A. Pediatric waitlist mortality has declined 53.4% since 2012, but remains substantial: 11.7 deaths per 100 patient-years. In 2023, 5-year posttransplant survival was 80.3% in adult recipients and 84.4% in pediatric recipients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationWaiting ListsTissue and Organ ProcurementTissue DonorsAnnual Reports as TopicRegistriesHumansUnited StatesAdultSurvival RateMalePrognosisFemale

Stichwörter der Autor:innen

Allocationdonorheart failureheart transplantleft ventricular assist devicemechanical circulatory supportoutcomes

Autor:innen und Institutionen

  • Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN; Department of Cardiology, University of Michigan, Ann Arbor, MI.
  • Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN; Department of Pediatrics, University of Washington, Seattle, WA.
  • Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN.
  • Organ Procurement and Transplantation Network, United Network for Organ Sharing, Richmond, VA.
  • Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN; Department of Medicine, University of Texas Medical Branch, Galveston, TX.
  • Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN; Department of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN; Department of Medicine, H…

Förderung

  • AHRQ HHS
  • Agency for Healthcare Research and Quality

Zitieren

APA

Colvin, M. M., Smith, J. M., Ahn, Y. S., Lindblad, K. A., Handarova, D., Israni, A. K., & Snyder, J. J. (2025). OPTN/SRTR 2023 Annual Data Report: Heart. American Journal of Transplantation, 25(2), S329-S421. https://doi.org/10.1016/j.ajt.2025.01.024

Vancouver

Colvin MM, Smith JM, Ahn YS, Lindblad KA, Handarova D, Israni AK, et al. OPTN/SRTR 2023 Annual Data Report: Heart. American Journal of Transplantation. 2025;25(2):S329-S421. doi:10.1016/j.ajt.2025.01.024

BibTeX
@article{Colvin2025,
  author = {Colvin, Monica M and Smith, Jodi M and Ahn, Yoon Son and Lindblad, Kelsi A and Handarova, Dzhuliyana and Israni, Ajay K and Snyder, Jon J},
  title = {OPTN/SRTR 2023 Annual Data Report: Heart},
  journal = {American Journal of Transplantation},
  year = {2025},
  volume = {25},
  number = {2},
  pages = {S329--S421},
  doi = {10.1016/j.ajt.2025.01.024}
}
Kostenlos starten →